Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆Xiaohua Wu, Mansoor Raza Mirza, Qi Zhou et al.|Annals of Oncology|2021Cited by 212
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian CancerNing Li, Lingying Wu, Jianqing Zhu et al.|JAMA Oncology|2023Cited by 165
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Linjuan Zeng, Jihong Liu et al.|Nature Medicine|2024Cited by 41
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trialXiaohua Wu, Mansoor Raza Mirza, Jianqing Zhu et al.|EClinicalMedicine|2024Cited by 24
Prevalence of and risk factors for chlamydia in female outpatients with genital tract infections: a nationwide multi-center, cross-sectional study in ChinaTing Li, Jianqing Zhang, Zhaohui Liu et al.|Frontiers in Public Health|2023Cited by 7